GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Long-Term Debt

NKGen Biotech (NKGen Biotech) Long-Term Debt : $10.15 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Long-Term Debt?

NKGen Biotech's Long-Term Debt for the quarter that ended in Mar. 2024 was $10.15 Mil.

NKGen Biotech's quarterly Long-Term Debt declined from Sep. 2023 ($14.71 Mil) to Dec. 2023 ($9.93 Mil) but then increased from Dec. 2023 ($9.93 Mil) to Mar. 2024 ($10.15 Mil).

NKGen Biotech's annual Long-Term Debt stayed the same from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($9.93 Mil).

NKGen Biotech Long-Term Debt Historical Data

The historical data trend for NKGen Biotech's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Long-Term Debt Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Long-Term Debt
- - 9.93

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial - - 14.71 9.93 10.15

NKGen Biotech  (NAS:NKGN) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

NKGen Biotech Long-Term Debt Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

NKGen Biotech (NKGen Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Long-Term Debt
Comparable Companies
OCUP CASI SPRO XLO NGM GBIO ASMB CCCC OCEA FIXX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
Website
https://www.nkgenbiotech.com
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.